Why a Hospital Stay Doesn't Bankrupt Families in Other Wealthy Countries

In the United States, a cancer diagnosis or a sudden cardiac event often triggers a dual burden for the patient: the physical challenge of recovery and the immediate threat to financial stability. As of 2024, approximately 1 in 12 American adults—roughly 20 million people—carried medical debt, according to a KFF analysis of Survey of Income and Program Participation (SIPP) data. The total national bill for this debt is estimated at $220 billion.

For the average American worker, whose hourly earnings stood at $34.75 in April 2024 according to the Bureau of Labor Statistics, a single major medical event can erode years of accumulated savings. With the U.S. consumer price index reaching 313.548 in April 2024, healthcare costs continue to outpace general inflation. Research published in the American Journal of Public Health indicates that medical expenses contribute to roughly 66.5 percent of all personal bankruptcies in the United States, a statistic that finds no equivalent in other developed economies.

The global landscape suggests that financial ruin following a diagnosis is a policy choice rather than an economic necessity. From the single-payer model in Taiwan to the social solidarity of France and the public-private hybrid in Australia, alternative systems demonstrate how to decouple healthcare delivery from individual insolvency.

The Efficiency of the Smart Card: Taiwan’s 1 Percent Solution

The economic signature of Taiwan’s healthcare system is its administrative overhead. As of 2023, the Taiwan National Health Insurance Administration (NHIA) reports that administrative costs sit at approximately 1 percent of total health expenditures. In the United States, the fragmented landscape of private insurers and complex billing requirements consumes between 15 and 30 percent of total spending on administration alone.

Taiwan’s National Health Insurance (NHI) system covered 99.9 percent of the population as of 2023. It operates as a single-payer model funded through a mix of premiums and taxes. The system utilizes a mandatory “Smart Card” which contains a patient’s medical history and automates the billing process. This digital integration reduces redundant testing and eliminates the need for extensive paperwork or “out-of-network” verification.

According to NHIA data, this “giant HMO” model allows patients total freedom of choice; citizens can see any specialist without a referral, yet the system avoids the price inflation common in other fee-for-service markets. To control costs, Taiwan employs a “Global Budget” system. According to the Journal of Formosan Medical Association in 2023, this system sets annual caps on spending, requiring providers to maintain high standards of care within a fixed budgetary framework.

The financial results are notable. Taiwan spends approximately 6.6 percent of its GDP on healthcare, according to 2023 figures. Despite this relatively low expenditure, citizens enjoy a life expectancy of 80.7 years, which remains higher than the U.S. average. By centralizing the payment structure and digitizing patient records, the system redirects funds from bureaucracy into actual patient care, largely eliminating the concept of medical debt for its citizens.

France and the Shield of Solidarity

The French approach to medical debt is rooted in the principle of “solidarity,” which dictates that healthcare contributions are based on income, while care is provided based on medical necessity. This ensures that healthcare remains accessible regardless of employment status, preventing the loss of insurance during a health crisis.

A central feature of this protection is the ‘Affection de Longue Durée’ (ALD) scheme. As of 2024, the French National Health Insurance Fund (Ameli) reports that patients diagnosed with any of 30 chronic illnesses—including cancer, diabetes, and heart disease—have 100 percent of their treatment costs covered by the state. This policy removes deductibles and co-pays for the most expensive and life-altering conditions.

For general medical care, the state typically covers about 70 percent of costs. However, the 2023 OECD Health at a Glance report indicates that 95 percent of the French population maintains ‘mutuelles’—private supplemental insurance—to cover remaining co-pays. These are frequently funded through employers, and for low-income individuals, the state provides free or highly subsidized supplemental coverage.

The effectiveness of this layered system is reflected in out-of-pocket spending, which accounts for only 9 percent of total health spending in France. Furthermore, the ‘Passerelle’ program ensures that even undocumented migrants have access to essential care. This policy aims to prevent public health crises and stop the accumulation of emergency room debt that would otherwise be absorbed by the public at a higher cost.

Australia’s Hybrid Safety Valve

Australia utilizes a hybrid model that balances a robust public system, known as Medicare, with a private sector that acts as a financial and operational safety valve. This dual-track approach provides universal coverage while allowing those who can afford it to pay for additional choices.

The primary defense against financial catastrophe in Australia is the ‘Medicare Safety Net.’ As of January 2024, the Australian Government Department of Health and Aged Care reported that once an individual or family reaches an out-of-pocket threshold of approximately $2,414, the government automatically covers 80 percent of further out-of-hospital costs for the remainder of the year.

Furthermore, the “Bulk Billing” system allows practitioners to bill the government directly for primary care visits. According to the Australian Institute of Health and Welfare in 2024, this results in a significant portion of the population paying $0 out-of-pocket for family physician visits. Prescription drugs are also regulated; the Pharmaceutical Benefits Scheme (PBS) capped the cost of most medicines at $31.60 for general patients and $7.70 for concession holders as of 2024.

To maintain the public system’s sustainability, the government uses a means-tested ‘Private Health Insurance Rebate.’ For the 2023/24 fiscal year, this subsidy reached up to 24.6 percent, encouraging higher-income citizens to utilize private insurance for elective surgeries and private hospital rooms. This system has contributed to a life expectancy of 83.3 years—among the highest globally—while maintaining health spending at 9.6 percent of GDP.

The Cost of the American Exception

The financial and health outcomes in the United States diverge significantly from these models. In 2022, U.S. healthcare spending reached $13,493 per person, according to CMS and OECD data. This is nearly double the per capita spending of Australia ($6,300) and France ($6,630).

Despite this investment, the 2024 Commonwealth Fund ‘Mirror, Mirror’ report ranks the U.S. last among 11 high-income countries in administrative efficiency and affordability. The human impact is visible in the data: the U.S. infant mortality rate was 5.4 per 1,000 live births in 2023, compared to 3.1 in Australia, 3.5 in France, and 3.9 in Taiwan.

Accessibility remains a primary concern. The Commonwealth Fund’s 2023 international survey found that 13 percent of Americans skipped necessary medical care because of the cost. In France, that number was less than 2 percent. According to the Commonwealth Fund, the financial structure of healthcare in other wealthy nations is designed to prevent a cancer diagnosis from leading to home foreclosure.

While the U.S. has recently moved to remove some medical debts from credit reports, the underlying debt persists. A 2024 study by the Consumer Financial Protection Bureau (CFPB) found that 15 percent of American credit reports still contain medical collections. In systems like Taiwan’s or France’s, the concept of a medical collection is largely non-existent due to the upfront coverage models.

Analysis: Price and Fragmentation

Critics often point to wait times as the price of universal care. Taiwan’s data suggests otherwise. The NHIA reports that patients in Taiwan often see specialists within 24 to 48 hours without a referral, while spending a fraction of the per-capita costs seen in the U.S.

The gap is driven largely by pricing and administrative fragmentation. The U.S. lacks a national mechanism to negotiate drug prices across all sectors or to implement “Global Budgets” for hospital systems. According to data from the OECD and various health policy studies, the U.S. spends a larger portion of its budget on the administration of care than on the care itself.

The models in Taipei, Paris, and Canberra demonstrate that universal coverage can be more cost-effective than fragmented private insurance. By eliminating middlemen and reducing the marketing and administrative costs associated with competing plans, these nations have lowered the barrier to entry for care.

For the 20 million Americans currently carrying medical debt, the situation remains a daily struggle against interest rates and collection agencies. As the U.S. looks toward the future of healthcare reform, the data from abroad provides clear examples of systems where a hospital stay is focused on recovery. In Australia, families have a defined safety net. In France, the tax system ensures that a neighbor’s illness does not become a shared financial crisis. In Taiwan, the Smart Card serves as a tool for administrative efficiency. These nations have secured a level of financial stability for their citizens that ensures the cost of treatment is not more damaging than the disease.